Protagonist Therapeutics PTGX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's change in accrued liabilities?
- Protagonist Therapeutics (PTGX) reported change in accrued liabilities of -$10.79M in Q1 2026.
- How has Protagonist Therapeutics's change in accrued liabilities changed year-over-year?
- Protagonist Therapeutics's change in accrued liabilities increased by 8.7% year-over-year, from -$11.82M to -$10.79M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.